We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $135M
1-Year Est. Return 0.15%
This Fund
S&P 500
This Quarter Est. Return
-5.45%
1 Year Est. Return
+0.15%
3 Year Est. Return
-0.04%
5 Year Est. Return
-7.65%
10 Year Est. Return
AUM
$115M
AUM Growth
Cap. Flow
+$34.4M
Cap. Flow %
29.86%
Top 10 Hldgs %
99.97%
Holding
14
New
9
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 98.38%
2 Technology 1.57%
3 Healthcare 0.03%
4 Energy 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN.PRA
1
DELISTED
Allergan plc
AGN.PRA
$22.4M 19.46%
+38,263
New +$24.7M
AGN
2
CALL
DELISTED
Allergan plc
AGN
$9.63M 8.36%
+58,900
New +$10.6M
SWNC
3
DELISTED
Southwestern Energy Company
SWNC
$6.86M 5.96%
+576,701
New +$7.69M
COUP
4
DELISTED
Coupa Software Incorporated
COUP
$1.81M 1.57%
+57,884
New +$1.96M
ZSAN
5
DELISTED
Zosano Pharma Corporation
ZSAN
$20K 0.02%
+56
New +$28.1K
RNGR icon
6
Ranger Energy Services
RNGR
$396M
$16K 0.01%
+1,700
New +$18.8K
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$7K 0.01%
+800
New +$6.84K
MDT icon
8
Medtronic
MDT
$118B
$6K 0.01%
+77
New +$6.17K
TNDM icon
9
Tandem Diabetes Care
TNDM
$1.38B
$6K 0.01%
+2,523
New +$7.92K

Similar funds

Piper Sandler & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Piper Sandler & Co held 14 positions worth $115M. Its ten largest holdings account for 100% of the portfolio.

Piper Sandler & Co deployed $34.4M of net new capital in Q4 2017, opening 9 new positions. Its largest new stake was Allergan plc: 38,263 shares worth $22.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 98% of assets, followed by Technology and Healthcare.

  • Piper Sandler & Co's largest Q4 2017 buy was Allergan plc: 38,263 shares worth $22.4M.
  • Piper Sandler & Co's ten largest holdings make up 100% of its $115M portfolio in Q4 2017.
  • Piper Sandler & Co opened 9 new positions and closed 0 in Q4 2017.

Based on Piper Sandler & Co's 13F filing for Q4 2017, filed 14 Feb 2018.